Sigit Adi Prasetyo

Sigit Adi Prasetyo

Auto-generated profile, based on publicly available information

Sigit Adi Prasetyo

Department of Surgery, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in International Surgery
Verified
Journal Article
Open access
IRIgnatius Riwanto
Ignatius Riwanto
SBSelamat Budijitno
Selamat Budijitno
EDEdi Dharmana
Edi Dharmana
DHDjoko Handojo
Djoko Handojo
SPSigit Adi Prasetyo
Sigit Adi Prasetyo
BPBondan Prasetyo
Bondan Prasetyo
The objective of this study was to know the response of supplementation of Phaleria macrocarpa (PM) to adriamycin-cyclophosphamide (AC) in the treatment of C3H mice with breast cancer. Twenty-four C3H mice, who were successfully inoculated with breast cancer cells, were randomly allocated into 4 groups: without treatment, treated with AC, treated with AC + PM 0.07 mg/d, and treated with AC + PM 0.14 mg/d. The tumor size was measured using millimeter calipers before and 12 weeks after treatment. The tumor, liver, and kidneys were removed and prepared for pathologic examination using imunohistochemistry staining, and the apoptotic index was counted using the terminal deoxynucleotidyl transferase dUTP nick end labeling method. AC reduce the tumor growth significantly (P < 0.001), whereas supplementation of PM, which significantly reduced the tumor growth compared with AC only, was at the 0.14 mg/d dose (P = 0.007). AC increase the apoptotic index significantly (P < 0.001), and supplementation with PM showed that the higher dose increased the apoptotic index. The correlation between the apoptotic index and the diameter of tumor was significantly negative (r = −0.884; P = 0.020). The apoptotic index of the liver and kidney increased significantly in the AC group (P < 0.001 and P = 0.002, respectively); supplementation with PM decreased significantly the high apoptotic index caused by AC. We conclude that PM supplementation has a synergic effect to AC treatment in reducing the tumor growth, by increasing apoptosis, and protects the liver and kidney from damage caused by AC.

1 December 2022 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
JHJonathan Alvin Nugraha Halim
Jonathan Alvin Nugraha Halim
ELEndang Sri Lestari
Endang Sri Lestari
SPSigit Adi Prasetyo
Sigit Adi Prasetyo
MMMuflihatul Muniroh
Muflihatul Muniroh
APAgung Aji Prasetyo
Agung Aji Prasetyo
BACKGROUND: Cholestasis caused by obstruction of the common bile duct and may developed gut-derived sepsis due to reactive oxygen species (ROS) accumulation. Ursodeoxycholic acid (UDCA) and glutathione are widely known for their antioxidant properties, that might be beneficial against ROS. However, the effects of UDCA-glutathione combination against ROS have not been well elucidated in previous studies. Thus, this study was conducted to evaluate tumor necrosis factor (TNF)-α level and height of terminal ileal mucosal villus after UDCA-glutathione administration in cholestasis rat model. METHODS: Twenty-eight male Sprague Dawley rats were randomly grouped into four treatment groups, each group consisted of seven rats that had previously undergone bile duct ligation. Three groups received treatment of UDCA-glutathione combination on stratified dose, while the other one only received UDCA. Each treatment was given for 21 days. Ileal samples were collected from the rats and stained with mouse anti TNF-a antibody and hematoxylin-eosin (HE). Immunohistochemistry and histopathological examination were done using microscope and then calculated with ImageJ. RESULTS: The combination of UDCA and glutathione treatment decreased the TNF-α expression (p<0.05) compared to UDCA only group, particularly in group that received 20 mg UDCA and 15 mg glutathione supplementation (p<0.05) and group that received 30 mg UDCA and 20 mg glutathione supplementation (p<0.05). The height of the mucosa villous was higher in the UDCA-glutathione combination groups for all the three dosage variations given (p<0.05) compared to UDCA only group. CONCLUSION: UDCA-glutathione combination downregulates TNF-α expression and improves ileum mucosal villus height in cholestasis. KEYWORDS: cholestasis, glutathione, intestinal villus height, TNF-α, UDCA

1 July 2025 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SBSelamat Budijitno
Selamat Budijitno
AAAldwin Arwidyardi
Aldwin Arwidyardi
ELEndang S. Lestari
Endang S. Lestari
SPSigit A. Prasetyo
Sigit A. Prasetyo
MMMuflihaul Mutniroh
Muflihaul Mutniroh
SPSistiya P. Putra
Sistiya P. Putra
Context: Cholestasis is marked by a disturbance in bile flow from the liver and potentially progresses to cirrhosis. Hepatic transplantation is the mainstay of therapy in hepatic cirrhosis, which is a high-cost, time-consuming, and complex procedure. Increasing evidence regarding the major role of gut microbiota in bile acid metabolism has prompted the effort to study probiotics as a potential alternative therapeutic strategy in chronic liver disease. Aims: To explore the effect of probiotic administration on Bifidobacterium, as part of the gut microbiota, and bilirubin levels in mice with cholestasis after biliary duct ligation who received standard ursodeoxycholic acid (UDCA) therapy. Methods: Thirty-five male Sprague Dawley rats were randomly assigned into seven groups: Sham-operated rats as healthy controls, cholestatic rats as negative control, UDCA only, probiotics only, and three groups received UDCA-probiotics on a stratified dose for 21 days. The bile duct ligation (BDL) procedure was used to induce cholestasis. Biochemical analyses were conducted for direct and total bilirubin levels, while Bifidobacterium DNA quantification was assessed with PCR. Results: BDL induces cholestasis, marked by a significant increase in direct and total bilirubin levels. The combination of UDCA-probiotics increased the amount of Bifidobacterium, with the highest dose of probiotics showing the highest amount, and the results were comparable among the other groups. The lowest direct and total bilirubin levels were found in the groups with the highest probiotics dose and UDCA combination. Conclusions: UDCA and probiotic combination significantly improved the amount of Bifidobacterium and bilirubin levels in cholestatic rats.

31 March 2021 in Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
Verified
Journal Article
Open access
PDF file
DPDilla Putri
Dilla Putri
SJSantoso Jaeri
Santoso Jaeri
APAgung Aji Prasetyo
Agung Aji Prasetyo
SPSigit Adi Prasetyo
Sigit Adi Prasetyo
Background: The incidence of cholesistolithiasis is increased due to the changes of diet to the western diet. The cholecystectomy is one of the treatments for cholecystolithiasis. It can be divided into laparoscopic cholecystectomy and laparotomy cholecystectomi. The previous study demonstrated that the laparoscopic cholecystectomy was better than laparotomy cholecystectomy for postoperative length of stay, surgical site infection, postoperative pain, and bile leak in cholecystolithiasis, but there is no official data and research yet in Indonesia Objective: To determine the difference of postoperative length of stay, surgical site infection, postoperative pain, and bile leak in laparoscopic cholecystectomy and laparotomy cholecystectomy.Methods: An analytic observational study with cross sectional design. Subject was patient who had undergone laparoscopic or laparotomy cholecystectomy from Dr Kariadi Hospital, Semarang and RSND Semarang during period of 2013 to 2019. The Mann Whitney-U test was used to determine the difference of length of stay as well the Chi Square test for determining the difference of surgical site infection, postoperative pain, and bile leak among both groups.Results: 34 (41.5%) men and 48 (58.5%) women with an age avarage of 49.84 ± 13.54 years were included. There were a significant difference between laparoscopic and laparotomy cholecystectomy in cholecystectolithiasis cases on postoperative hospital stay (p = 0.000), postoperative pain (p = 0.000), surgical site nfection (p = 0.000), and bile leak ( p = 0.013).Conclusion: Laparoscopic cholecystectomy was better than open cholecystectomy in postoperative hospital stay, surgical site infection, postoperative pain, and bile leak for cholecystolithiasis cases. Keywords: bile leak , cholecystetomy, cholecystolithiasis, laparoscopy, laparotomy

1 April 2026 in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Verified
Journal Article
Open access
PDF file
SPSigit Adi Prasetyo
Sigit Adi Prasetyo
PBParish Budiono
Parish Budiono
NWNani Wijaya
Nani Wijaya
IRIgnatius Riwanto
Ignatius Riwanto
Giant serous cystadenoma (SCA) of the pancreas is a rare benign tumor that typically remains asymptomatic and undetected until it reaches a considerable size, highlighting the diagnostic challenge in differentiating it from other pancreatic cystic lesions. This study seeks to present an uncommon instance of giant pancreatic SCA and underscore the diagnostic and therapeutic methodology. A case report design was used involving a 35-year-old female patient presenting with a painless epigastric mass without associated gastrointestinal or systemic symptoms. Physical examination revealed a firm, non-tender mass in the left upper abdomen. Diagnostic imaging using contrast-enhanced computed tomography (CT) identified a 15 cm multiloculated cystic lesion with thin septations and central calcifications in the body and tail of the pancreas. Surgical intervention consisted of distal pancreatectomy and splenectomy. Histopathological examination confirmed a diagnosis of serous cystadenoma confined to the pancreatic tail, characterized by multiple cystic spaces lined with cuboidal epithelium and clear cytoplasm. The patient experienced an uneventful recovery and was discharged on the fifth postoperative day. This case underscores the critical role of radiologic evaluation in differentiating SCAs from other cystic lesions such as pseudocysts and mucinous cystadenomas to support accurate preoperative planning. The findings suggest that, despite their benign nature, early recognition and surgical management of large SCAs are essential to preventing complications, and improved awareness is needed to enhance diagnostic accuracy and avoid overtreatment or delayed intervention.

27 December 2024 in Jurnal Kedokteran dan Kesehatan Indonesia
Verified
Journal Article
Open access
PDF file
ASAnindhita Dyah Sekartaji
Anindhita Dyah Sekartaji
SPSigit Adi Prasetyo
Sigit Adi Prasetyo
MMMuflihatul Muniroh
Muflihatul Muniroh
Background: Cholestasis is a disturbance in the production or flow of bile that causes excessive accumulation of bile fluid and damage in the liver. Chronic liver damage will lead to liver fibrosis. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitors of metalloprotease-1 (TIMP-1) play a critical role in liver fibrosis formation. Although ursodeoxycholic acid (UDCA) and Allium sativum extracts have long been renowned for improving liver function, their combination in alleviating liver fibrosis through the MMP-9 and TIMP-1 inhibitory pathways has yet to be studied.Objective: This study was conducted to assess the efficacy of UDCA and Allium sativum extract combination in altering MMP-9 and TIMP-1 levels, which are the main factors in the progression of liver fibrosis.Methods: We performed an experimental study with a post-test-only control group on 36 Sprague-Dawley rats, which were randomly grouped into healthy, negative, positive, and three treatment groups with UDCA (13.5 mg) and graded doses of Allium sativum extract (3.6 mg; 7.2 mg; and 14.4 mg). Cholestasis induction was done by a choledochal duct ligation, and treatment was given for 14 days. Levels of MMP-9 and TIMP-1 were analyzed after treatment.Results: Combining UDCA and Allium sativum improved the MMP-9 levels significantly in cholestatic rats, compared to administrating UDCA only (p <0.05). Combining UDCA and Allium sativum increased the TIMP-1 level (p < 0.05). Although the MMP-9 level results were under our existing hypothesis, TIMP-1 results showed surprising results. Matrix metalloproteinase-9 levels were strongly negatively correlated with TIMP-1 levels, with a r-value= 0.981.Conclusion: Combining Allium sativum and UDCA alleviates liver fibrosis progression through lowering levels of MMP-9 and increasing levels of TIMP-1.